PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Madhavan, B.K.* ; Han, Z.* ; Singh, B.* ; Bordt, N.* ; Kaymak, S.* ; Bandapalli, O.R.* ; Kihm, L.* ; Shahzad, K.* ; Isermann, B.* ; Herzig, S. ; Nawroth, P.P.* ; Kumar, V.*

Elevated expression of the rage variant-v in sclc mitigates the effect of chemotherapeutic drugs.

Cancers 13:2843 (2021)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Small cell lung carcinoma (SCLC) is a highly aggressive malignancy with a very high mortality rate. A prominent part of this is because these carcinomas are refractory to chemotherapies, such as etoposide or cisplatin, making effective treatment almost impossible. Here, we report that elevated expression of the RAGE variant-V in SCLC promotes homology-directed DNA DSBs repair when challenged with anti-cancer drugs. This variant exclusively localizes to the nucleus, interacts with members of the double-strand break (DSB) repair machinery and thus promotes the recruitment of DSBs repair factors at the site of damage. Increased expression of this variant thus, promotes timely DNA repair. Congruently, the tumor cells expressing high levels of variant-V can tolerate chemotherapeutic drug treatment better than the RAGE depleted cells. Our findings reveal a yet undisclosed role of the RAGE variant-V in the homology-directed DNA repair. This variant thus can be a potential target to be considered for future therapeutic approaches in advanced SSLC.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
6.639
1.292
2
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Dna Repair ; Invasion ; Laser Induced Dna Damage ; Migration ; Rage ; Small Cell Lung Carcinoma ; Wound Healing; Glycation End-products; Cell Lung-cancer; Targeting Dna-damage; Web Server; Subcellular-localization; Splice Variants; Receptor; Protein; Apoptosis; Biology
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 2072-6694
Zeitschrift Cancers
Quellenangaben Band: 13, Heft: 11, Seiten: , Artikelnummer: 2843 Supplement: ,
Verlag MDPI
Verlagsort St Alban-anlage 66, Ch-4052 Basel, Switzerland
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Cancer (IDC)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-501900-251
Förderungen Foundation for Diabetes Research
Helmholtz Cross Program Topic Metabolic Dysfunction
DZD
Deutsche Forschungsgemeinschaft
DOI 10.3390/cancers13112843
WOS ID WOS:000659598200001
Scopus ID 85107295569
PubMed ID 34200336
Erfassungsdatum 2021-07-09
[➜Korrektur melden]